Norwegian diagnostics company Genetic Analysis has appointed Mira Halvorsen Børstad as Chief Commercial Officer, CCO, according to a press release. She took up the position on September 1 and will become a member of group management, reporting to CEO Ronny Hermansen. Børstad joins from Curida, where she was Commercial Director, Biologics & Dx Solutions. She will have overall responsibility for Genetic Analysis' commercial operations, including strategy, product prioritization and strategic partnerships.